GoodRx (NASDAQ:GDRX) & Mullen Automotive (NASDAQ:MULN) Head to Head Analysis

GoodRx (NASDAQ:GDRXGet Rating) and Mullen Automotive (NASDAQ:MULNGet Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Earnings & Valuation

This table compares GoodRx and Mullen Automotive’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
GoodRx $745.42 million 9.77 -$25.25 million ($0.07) -259.53
Mullen Automotive $65.71 million 1.41 -$36.46 million ($0.66) -4.03

GoodRx has higher revenue and earnings than Mullen Automotive. GoodRx is trading at a lower price-to-earnings ratio than Mullen Automotive, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

54.4% of GoodRx shares are held by institutional investors. Comparatively, 66.9% of Mullen Automotive shares are held by institutional investors. 1.4% of GoodRx shares are held by insiders. Comparatively, 84.7% of Mullen Automotive shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares GoodRx and Mullen Automotive’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
GoodRx -3.39% 0.06% 0.03%
Mullen Automotive N/A N/A -121.25%

Volatility and Risk

GoodRx has a beta of -0.47, indicating that its share price is 147% less volatile than the S&P 500. Comparatively, Mullen Automotive has a beta of 2.47, indicating that its share price is 147% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for GoodRx and Mullen Automotive, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx 1 6 11 0 2.56
Mullen Automotive 0 0 0 0 N/A

GoodRx presently has a consensus price target of $30.22, suggesting a potential upside of 66.33%. Given GoodRx’s higher probable upside, analysts clearly believe GoodRx is more favorable than Mullen Automotive.

Summary

GoodRx beats Mullen Automotive on 8 of the 12 factors compared between the two stocks.

About GoodRx (Get Rating)

GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

About Mullen Automotive (Get Rating)

Mullen Automotive, Inc., an electric vehicle company, manufactures and distributes electric vehicles. It also operates CarHub, a digital platform that leverages AI to offer an interactive solution for buying, selling, and owning a car; and provides battery technology and emergency point-of-care solutions. The company was founded in 2014 and is based in Brea, California.

Receive News & Ratings for GoodRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoodRx and related companies with MarketBeat.com's FREE daily email newsletter.